Views & Analysis | Perspectives on pharma industry issues

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Patients

Breaking Bipolar I disorder stigma in the Hispanic community

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Digital

AI-native clinical research concept of HCP, clipboard, and AI capabilities overlain

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.

Articles

Five lessons from GSK in social media

In pharmaphorum's Digital and social media themed month, Daniel Ghinn explores GSK's use of social media and the milestones it has reached to achieve its current success in this space.

Articles

Your health, yourself: Conclusion

In the concluding part of this series by Ogilvy CommonHealth Worldwide on the quantified-self movement, we review what we have learnt by meeting our five patients with their separate health con

Articles

Looking within pharma for social media inspiration

Hot on the heels of the publication of Ogilvy Healthworld's white paper comparing how social different pharma companies are, pharmaphorum's Paul Tunnah speaks with Joanne Wunder and Leo Ryan to

Sales & Marketing

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their

Sales & Marketing

Are Insights leaders seeing real commercial value from AI ad...

Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Digital

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.